Thus, our findings suggest that obesity‐induced decrease or aerobic exercise training‐induced increase in circulating FSTL1 levels may be associated with changes in arterial NO production via the Akt‐eNOS signaling pathway without changes in the arterial FSTL1 receptor expression levels. Here, FSTL1 is linked to obesity disorder.